{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:05:02Z","timestamp":1788213902550,"version":"build-2803163510"},"reference-count":58,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006541","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD-7321"],"award-info":[{"award-number":["P2022\/BMD-7321"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Major depressive disorder (MDD) is a complex psychiatric disorder that, presented alone or with other comorbidities, requires different adjustments of antidepressant treatments. Some investigations have demonstrated that psychoactive drugs, such as serotonin and norepinephrine reuptake inhibitors (SNRIs), can exert more effective and faster antidepressant effects than other common medications used, such as serotonin selective reuptake inhibitors (SSRIs), although these differences are still controversial. During the last five years, the SNRI duloxetine has shown favorable results in clinical practice for the treatment of MDD, anxiety, and fibromyalgia. Through an online self-completed survey, in the present article, we collected information from 163 psychiatrists regarding the use of duloxetine and its comparison with other psychiatric drugs, concerning psychiatrists\u2019 knowledge and experience, as well as patients\u2019 preferences, symptoms, and well-being. We discussed and contrasted physicians\u2019 reports and the scientific literature, finding satisfactory concordances, and finally concluded that there is agreement regarding the use of duloxetine, not only due to its tolerability and effectiveness but also due to the wide variety of situations in which it can be used (e.g., somatic symptoms in fibromyalgia, diabetes) as it relieves neuropathic pain as well.<\/jats:p>","DOI":"10.3390\/brainsci13020333","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T05:37:46Z","timestamp":1676439466000},"page":"333","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Current Opinions about the Use of Duloxetine: Results from a Survey Aimed at Psychiatrists"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1987-0394","authenticated-orcid":false,"given":"M. A.","family":"Alvarez-Mon","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Mental Health, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain"},{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-7855","authenticated-orcid":false,"given":"Cielo","family":"Garc\u00eda-Montero","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-6397","authenticated-orcid":false,"given":"Oscar","family":"Fraile-Martinez","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Quintero","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain"},{"name":"Department of Legal Medicine and Psychiatry, Complutense University, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-8808","authenticated-orcid":false,"given":"Sonia","family":"Fernandez-Rojo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4698-1679","authenticated-orcid":false,"given":"Fernando","family":"Mora","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain"},{"name":"Department of Legal Medicine and Psychiatry, Complutense University, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0082-2189","authenticated-orcid":false,"given":"Luis","family":"Guti\u00e9rrez-Rojas","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Granada, 18016 Granada, Spain"},{"name":"Psychiatry Service, San Cecilio University Hospital, 18016 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Molina-Ruiz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health, Hospital Universitario Cl\u00ednico San Carlos, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6152-3564","authenticated-orcid":false,"given":"Guillermo","family":"Lahera","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"},{"name":"Department of Psychiatry, University Hospital Pr\u00edncipe de Asturias, 28805 Alcal\u00e1 de Henares, Spain"},{"name":"Mental Health Networking Biomedical Research Centre (CIBERSAM), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1309-7510","authenticated-orcid":false,"given":"Melchor","family":"\u00c1lvarez-Mon","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"},{"name":"Immune System Diseases-Rheumatology and Internal Medicine Service, University Hospital Pr\u00edncipe de Asturias, CIBEREHD, 28806 Alcal\u00e1 de Henares, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2588-1708","authenticated-orcid":false,"given":"Miguel A.","family":"Ortega","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/1516-4446-2020-0650","article-title":"Prevalence and Correlates of Major Depressive Disorder: A Systematic Review","volume":"42","author":"Dunne","year":"2020","journal-title":"Braz. J. Psychiatry"},{"key":"ref_2","first-page":"1517","article-title":"Depression Is the Leading Cause of Disability around the World","volume":"317","author":"Friedrich","year":"2017","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae), American Psychiatric Association.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ortega, M.A., Alvarez-Mon, M.A., Garc\u00eda-Montero, C., Fraile-Martinez, O., Guijarro, L.G., Lahera, G., Monserrat, J., Valls, P., Mora, F., and Rodr\u00edguez-Jim\u00e9nez, R. (2022). Gut Microbiota Metabolites in Major Depressive Disorder-Deep Insights into Their Pathophysiological Role and Potential Translational Applications. Metabolites, 12.","DOI":"10.3390\/metabo12010050"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Alvarez-Mon, M.A., Ortega, M.A., Garc\u00eda-Montero, C., Fraile-Martinez, O., Monserrat, J., Lahera, G., Mora, F., Rodriguez-Quiroga, A., Fernandez-Rojo, S., and Quintero, J. (2021). Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects. Pharmaceuticals, 14.","DOI":"10.3390\/ph14080821"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fnut.2022.867150","article-title":"Nutrition, Epigenetics, and Major Depressive Disorder: Understanding the Connection","volume":"9","author":"Ortega","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2017.12.025","article-title":"Understanding the Pathophysiology of Depression: From Monoamines to the Neurogenesis Hypothesis Model\u2014Are We there yet?","volume":"341","author":"Jesulola","year":"2018","journal-title":"Behav. Brain Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/imm.12443","article-title":"Immune Mechanisms Linked to Depression via Oxidative Stress and Neuroprogression","volume":"144","author":"Bakunina","year":"2015","journal-title":"Immunology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","article-title":"The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)","volume":"39","author":"Greenberg","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.euroneuro.2021.04.022","article-title":"Epidemiology and Costs of Depressive Disorder in Spain: The EPICO Study","volume":"50","author":"Vieta","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.4103\/0019-5545.196973","article-title":"Clinical Practice Guidelines for the Management of Depression","volume":"59","author":"Gautam","year":"2017","journal-title":"Indian J. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults with Major Depressive Disorder: A Systematic Review and Network Meta-Analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"ref_13","unstructured":"Dhaliwal, J.S., Spurling, B.C., and Molla, M. (2022). Duloxetine. Essence Analg. Analg., 353\u2013356."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: Their Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr."},{"key":"ref_15","first-page":"37","article-title":"Serotonin Norepinephrine Reuptake Inhibitors: A Pharmacological Comparison","volume":"11","author":"Sansone","year":"2014","journal-title":"Innov. Clin. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jocn.2020.08.013","article-title":"Application of Antidepressants in Depression: A Systematic Review and Meta-Analysis","volume":"80","author":"Yuan","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1136\/bmj.309.6968.1546","article-title":"Choice of Antidepressants: Questionnaire Survey of Psychiatrists and General Practitioners in Two Areas of Sweden","volume":"309","author":"Isacsson","year":"1994","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.4088\/JCP.v69n1209","article-title":"Why don\u2019t Psychiatrists Use Scales to Measure Outcome when Treating Depressed Patients?","volume":"69","author":"Zimmerman","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liu, F., and Demosthenes, P. (2022). Real-World Data: A Brief Review of the Methods, Applications, Challenges and Opportunities. BMC Med. Res. Methodol., 22.","DOI":"10.1186\/s12874-022-01768-6"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bozzatello, P., Giordano, B., Montemagni, C., Rocca, P., and Bellino, S. (2022). Real-World Functioning in Psychiatric Outpatients: Predictive Factors. J. Clin. Med., 11.","DOI":"10.3390\/jcm11154400"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"de Anta, L., Alvarez-Mon, M.A., Ortega, M.A., Salazar, C., Donat-Vargas, C., Santoma-Vilaclara, J., Martin-Martinez, M., Lahera, G., Gutierrez-Rojas, L., and Rodriguez-Jimenez, R. (2022). Areas of Interest and Social Consideration of Antidepressants on English Tweets: A Natural Language Processing Classification Study. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020155"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/tmj.2022.0051","article-title":"Evaluating the Effect of a Telepsychiatry Educational Program on the Awareness, Knowledge, Attitude, and Skills of Telepsychiatry among Spanish Psychiatrists during COVID-19 Pandemic","volume":"29","author":"Grande","year":"2023","journal-title":"Telemed. J. E. Health."},{"key":"ref_23","unstructured":"Singh, D., and Saadabadi, A. (2022). Venlafaxine. xPharm Compr. Pharmacol. Ref., 1\u20135."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A Brief History of the Development of Antidepressant Drugs: From Monoamines to Glutamate","volume":"23","author":"Hillhouse","year":"2015","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"108237","DOI":"10.1016\/j.neuropharm.2020.108237","article-title":"SNRIs Achieve Faster Antidepressant Effects than SSRIs by Elevating the Concentrations of Dopamine in the Forebrain","volume":"177","author":"Li","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2710.2009.01050.x","article-title":"Comparison of SSRIs and SNRIs in Major Depressive Disorder: A Meta-Analysis of Head-to-Head Randomized Clinical Trials","volume":"35","author":"MacHado","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_27","first-page":"58","article-title":"Are SNRIs more Effective than SSRIs? A Review of the Current State of the Controversy\u2014PubMed","volume":"41","author":"Thase","year":"2008","journal-title":"Psychopharmacol. Bull."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cipriani, A., La Ferla, T., Furukawa, T.A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., and Barbui, C. (2009). Sertraline versus Other Antidepressive Agents for Depression. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD006117.pub2"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6699028","article-title":"Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review","volume":"2021","author":"Marasine","year":"2021","journal-title":"Biomed Res. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40261-016-0399-6","article-title":"Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial","volume":"36","author":"Mowla","year":"2016","journal-title":"Clin. Drug Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.4088\/JCP.v66n1015","article-title":"Randomized Trial of Sertraline versus Venlafaxine XR in Major Depression: Efficacy and Discontinuation Symptoms","volume":"66","author":"Sir","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2165\/00023210-200721070-00004","article-title":"Duloxetine: A Review of Its Use in the Treatment of Major Depressive Disorder","volume":"21","author":"Frampton","year":"2007","journal-title":"CNS Drugs"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"554899","DOI":"10.3389\/fpsyt.2020.554899","article-title":"A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine","volume":"11","author":"Olivares","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1517\/14740338.2011.582037","article-title":"Adverse Reactions to Duloxetine in Depression","volume":"10","author":"Bitter","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1517\/14740338.4.6.987","article-title":"Safety and Adverse Event Profile of Duloxetine","volume":"4","author":"Wernicke","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_36","first-page":"CD006533","article-title":"Duloxetine versus Other Anti-Depressive Agents for Depression","volume":"10","author":"Cipriani","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_37","first-page":"321","article-title":"Duloxetine versus Venlafaxine in the Treatment of Unipolar and Bipolar Depression\u2014PubMed","volume":"161","author":"Serafini","year":"2010","journal-title":"Clin Ter."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1185\/03007995.2011.576663","article-title":"Treatment Adherence and Persistence with Duloxetine, Venlafaxine XR, and Escitalopram among Patients with Major Depressive Disorder and Chronic Pain-Related Diseases","volume":"27","author":"Wang","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0447.2010.01599.x","article-title":"A Systematic Review of Duloxetine and Venlafaxine in Major Depression, including Unpublished Data","volume":"123","author":"Schueler","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-11-19","article-title":"Treatment Patterns Associated with Duloxetine and Venlafaxine Use for Major Depressive Disorder","volume":"11","author":"Ye","year":"2011","journal-title":"BMC Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/JCP.0b013e318160d609","article-title":"Combining Mirtazapine and Duloxetine in Treatment-Resistant Depression Improves Outcomes and Sexual Function","volume":"28","author":"Lavindran","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jpsychires.2013.02.013","article-title":"Chronic Administration of Duloxetine and Mirtazapine Downregulates Proapoptotic Proteins and Upregulates Neurotrophin Gene Expression in the Hippocampus and Cerebral Cortex of Mice","volume":"47","author":"Engel","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4088\/PCC.v10n0307","article-title":"Combination Treatment with Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review","volume":"10","author":"Dunlop","year":"2008","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"ref_44","first-page":"137","article-title":"Clinical Guidance for the Use of Trazodone in Major Depressive Disorder and Concomitant Conditions: Pharmacology and Clinical Practice","volume":"54","author":"Cuomo","year":"2019","journal-title":"Riv. Psichiatr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15622970701586331","article-title":"Non-Fatal Overdose of Duloxetine in Combination with Other Antidepressants and Benzodiazepines","volume":"10","author":"Menchetti","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41419-022-05042-x","article-title":"High-Content Imaging of Human Hepatic Spheroids for Researching the Mechanism of Duloxetine-Induced Hepatotoxicity","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4088\/JCP.v67n0510","article-title":"Duloxetine Efficacy for Major Depressive Disorder in Male vs. Female Patients: Data from 7 Randomized, Double-Blind, Placebo-Controlled Trials","volume":"67","author":"Kornstein","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jad.2006.04.006","article-title":"Duloxetine in the Treatment of Major Depressive Disorder: Comparisons of Safety and Tolerability in Male and Female Patients","volume":"94","author":"Stewart","year":"2006","journal-title":"J. Affect. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/00926230252851267","article-title":"SSRI Sexual Dysfunction: A Female Perspective","volume":"28","author":"Hensley","year":"2002","journal-title":"J. Sex Marital Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4088\/PCC.v08n0503","article-title":"Effects of the Antidepressant Duloxetine on Body Weight: Analyses of 10 Clinical Studies","volume":"8","author":"Wise","year":"2006","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.euroneuro.2013.05.001","article-title":"Side Effects of Antidepressants during Long-Term Use in a Naturalistic Setting","volume":"23","author":"Bet","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e18834","DOI":"10.1097\/MD.0000000000018834","article-title":"Evaluation of Duloxetine and Innovative Pelvic Floor Muscle Training in Women with Stress Urinary Incontinence (DULOXING): Study Protocol Clinical Trial (SPIRIT Compliant)","volume":"99","author":"Hagovska","year":"2020","journal-title":"Medicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.euf.2020.06.007","article-title":"Use of Duloxetine for Postprostatectomy Stress Urinary Incontinence: A Systematic Review","volume":"7","author":"Kotecha","year":"2021","journal-title":"Eur. Urol. Focus"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1176\/appi.psy.45.1.17","article-title":"Effects of Duloxetine on Painful Physical Symptoms Associated with Depression","volume":"45","author":"Goldstein","year":"2004","journal-title":"Psychosomatics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3928\/0279-3695-20031201-08","article-title":"Physical Symptoms Comorbid with Depression and the New Antidepressant Duloxetine","volume":"41","author":"Bailey","year":"2003","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"818522","DOI":"10.3389\/fneur.2022.818522","article-title":"Comparative Efficacy and Safety of 11 Drugs as Therapies for Adults with Neuropathic Pain after Spinal Cord Injury: A Bayesian Network Analysis Based on 20 Randomized Controlled Trials","volume":"13","author":"Ling","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e01527","DOI":"10.1002\/brb3.1527","article-title":"Duloxetine and Pregabalin in Neuropathic Pain of Lung Cancer Patients","volume":"10","author":"Tepetam","year":"2020","journal-title":"Brain Behav."},{"key":"ref_58","first-page":"e28683","article-title":"A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain","volume":"14","author":"Shah","year":"2022","journal-title":"Cureus J. Med. Sci."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/2\/333\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:36:34Z","timestamp":1760121394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/2\/333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["brainsci13020333"],"URL":"https:\/\/doi.org\/10.3390\/brainsci13020333","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]}}}